drug
MORF-057
Phase 2updated 3mo agoby Eli Lilly and Co
Phase 2community read0 votes
indications
indications
IBD (Crohn's + UC)
all catalysts(0)
nothing on the calendar yet
Trials studying MORF-057
- phase2A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- phase2A Phase 2a Open-Label Study to Evaluate the Efficacy and Safety of MORF-057 in Adults With UC
- phase2A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC
- phase1Study of MORF 057 to Evaluate Single and Multi Ascending Doses in Healthy Volunteers
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 6m ago
Found something off?
comments(0)
5-min edit window · permanent after that